To determine whether Silibinin regulates SLC1A5 expression to mediate GBM progression, A172 and U251 cells are transfected with pcDNA/SLC1A5 overexpression vector and then treated with Silibinin. This evidence concerns the gene SLC1A5 and glioblastoma.